Despite improvements in management, S. aureus remains a major cause of mastitis. Its chronic and destructive nature often leads to premature culling and ample loss of revenue. Additional help was sought in the form of a mastitis vaccine to overcome this challenge. The study investigated the ability of a mastitis vaccine to reduce new intra-mammary infections (IMI) with Staphylococcus aureus (S. aureus), improve bacterial cure, and reduce the duration of IMI and to investigate its effect on milk somatic cell count.
A controlled field study investigating the effects of a mastitis vaccine in a Staphylococcus aureus positive dairy herd
This online calculator will allow you to know your farm costs, find out the costs associated with clinical and subclinical mastitis and analyse the production losses associated with mastitis
Discover our latest news